We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

199 hedge funds and large institutions have $2.33B invested in Heron Therapeutics in 2019 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 78 increasing their positions, 51 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

169% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 16

53% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 51

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

38% more capital invested

Capital invested by funds: $1.69B → $2.33B (+$635M)

11% more funds holding

Funds holding: 180 → 199 (+19)

3% more call options, than puts

Call options by funds: $4.93M | Put options by funds: $4.8M

4.56% less ownership

Funds ownership: 114.55% → 109.99% (-4.6%)

Holders
199
Holders Change
+19
Holders Change %
+10.56%
% of All Funds
3.92%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
43
Increased
78
Reduced
51
Closed
16
Calls
$4.93M
Puts
$4.8M
Net Calls
+$131K
Net Calls Change
-$2.66M

Top Buyers

1
Franklin Resources
Franklin Resources
California
+$44.8M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$26.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$19.9M
4
FCM
Farallon Capital Management
California
+$19.4M
5
Goldman Sachs
Goldman Sachs
New York
+$18.8M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$42.4M
2
BM
Bridger Management
New York
-$15.6M
3
TCM
Tang Capital Management
California
-$11M
4
KCM
Kingdon Capital Management
New York
-$9.36M
5
NAM
Nexpoint Asset Management
Texas
-$6.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
76
Broadfin Capital
New York
$2.11M -$188K -8,507 -9%
OTPPB
77
Ontario Teachers' Pension Plan Board
Ontario, Canada
$2.08M +$1.96M +88,482 New
Barclays
78
Barclays
United Kingdom
$2.07M -$137K -6,184 -7%
ARTA
79
A.R.T. Advisors
New York
$1.96M -$958K -43,291 -34%
Squarepoint
80
Squarepoint
New York
$1.87M +$1.76M +79,680 New
RSS
81
Rosenblum Silverman Sutton
California
$1.87M -$1.34M -60,564 -43%
Fisher Asset Management
82
Fisher Asset Management
Washington
$1.77M +$1.7K +77 +0.1%
KOCAA
83
Knights of Columbus Asset Advisors
Connecticut
$1.75M +$1.65M +74,680 New
RA
84
Royce & Associates
New York
$1.71M +$57.5K +2,600 +4%
SIM
85
Spark Investment Management
New York
$1.54M – – –
MSL
86
Mackay Shields LLC
New York
$1.46M -$323K -14,600 -19%
TCM
87
Tekla Capital Management
Massachusetts
$1.41M +$1.32M +59,842 New
WG
88
Winton Group
United Kingdom
$1.31M +$592K +26,769 +92%
Envestnet Asset Management
89
Envestnet Asset Management
Illinois
$1.3M +$53.7K +2,427 +5%
AIG
90
American International Group
New York
$1.24M +$133K +6,030 +13%
Wells Fargo
91
Wells Fargo
California
$1.22M -$275K -12,451 -19%
OAM
92
Oxford Asset Management
United Kingdom
$1.21M +$1.14M +51,548 New
ACI
93
AMP Capital Investors
Australia
$1.2M – – –
SI
94
Sofinnova Investments
California
$1.19M -$1.17M -53,102 -51%
3C
95
361 Capital
Colorado
$1.18M +$1.11M +50,171 New
MWVC
96
Morgens Waterfall Vintiadis & Co
New York
$1.18M +$243K +11,000 +28%
Royal Bank of Canada
97
Royal Bank of Canada
Ontario, Canada
$1.15M +$692K +31,282 +176%
TI
98
Trexquant Investment
Connecticut
$1.12M +$1.05M +47,651 New
Legal & General Group
99
Legal & General Group
United Kingdom
$1.1M +$134K +6,045 +15%
UONDDL
100
University of Notre Dame du Lac
Indiana
$1.08M -$151K -6,817 -13%
2 3
4
5 6

HRTX Hedge Fund Activity: Q4 2019 in Review

199 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2019, worth a combined $2.33B — up 38% from $1.69B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new HRTX positions and 16 closed out — a net gain of 27 holders — while 78 added to existing stakes and 51 trimmed.

The largest buyer was Franklin Resources, adding an estimated $44.8M. The largest seller was Fidelity Investments, cutting an estimated $42.4M.

  • 199 institutional investors held Heron Therapeutics (HRTX) as of Q4 2019, up from 180 in Q3 2019.
  • Funds reported $2.33B of Heron Therapeutics stock for Q4 2019, up 38% quarter-over-quarter.
  • 43 funds opened new Heron Therapeutics positions in Q4 2019 and 16 closed out, a net change of +27 holders.
  • The largest Heron Therapeutics buyer in Q4 2019 was Franklin Resources, an estimated $44.8M added.
  • The largest Heron Therapeutics seller in Q4 2019 was Fidelity Investments, an estimated $42.4M sold.

Based on aggregated 13F filings for Q4 2019.